Related Experiment Video
Updated: Mar 23, 2026

The Intra-Aortic Balloon Pump
Published on: February 5, 2021
Dilatable pulmonary artery band: Safety and efficacy of balloon dilatation
Sophie Malekzadeh-Milani1, Zakaria Jalal1, Daniel Tamisier1
1Centre de Référence Malformations Cardiaques Congénitales Complexes - M3C, Necker Hospital for Sick Children, George Pompidou European Hospital, Assistance Publique des Hopitaux de Paris, Paris, France.
Objectives:
Review early and midterm results of dilatable pulmonary artery band (PAB).
Background:
PAB is performed in various conditions: as a transient stage before ventricular septal defect (VSD) closure, as a palliative procedure for multiple VSD or to prepare the left ventricle (LV) before switch or double switch operations in transposition of the great artery (TGA) or congenitally corrected transposition of great arteries (CCTGA).
Methods:
All children with dilatation of PAB were reviewed. Reason for PAB and for cardiac catheterization, hemodynamics, and outcomes were analyzed.
Results:
Between 2002 and 2014, 28 patients were identified. Reason for interventional dilatation of the PAB was supra systemic right ventricular (RV) pressure in four patients, aortic recoarctation in one patient, cyanosis in seven patients, RV failure in one patient, suprasystemic LV pressure in two CCTGA patients and spontaneous closure of VSD in other patients. All patients underwent successful balloon dilatation using high (n = 21) or low pressure balloons with a mean diameter of 12 mm. 23 Patients had no further interventions. Five patients had reintervention: one needed two dilatations of PAB and four had surgery (one double switch, one vicious pulmonary artery (PA) band removal, one in a context of severe RV dysfunction with tricuspid regurgitation, and one for VSD closure). One patient died of RV failure following surgery.
Conclusion:
Balloon dilatation of dilatable PAB carries good results with achievement of hemodynamic aim in most of the cases and definitive treatment in the majority of patients. Careful and sequential dilatation with shunt measurement is mandatory in patients with significantly residual VSD. © 2016 Wiley Periodicals, Inc.
More Related Videos
06:59Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
06:51Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
Published on: October 20, 2023
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...